Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports.

Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

Analysts' ratings for Vertex Pharmaceuticals VRTX over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings, showcasing the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

research-stage immunoprotective approaches - BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several updates on the Company’s type 1 diabetes (T1D) ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...

Of those 11, the company believed to have the lowest potential exposure to tariffs is Vertex Pharmaceuticals (NASDAQ: VRTX), since all of its manufacturing occurs within the United States ...

PROVIDENCE, RI (WJAR) — Two people were charged after a shooting and police chase in Providence Thursday night. Police Chief Oscar Perez said officers responded to reports of shots fired in the ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $502.55, marking a +0.45% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%.

Prepare for an unforgettable journey into the heart of wine culture at the inaugural Rhode Island Wine Experience, part of the Providence Culinary Collective with Go Providence. This festival ...

Speaking on Thursday, Trump suggested there would also be specific tariffs on pharmaceuticals as the US "doesn't make anything" in terms of drugs and medicines. "It's in other countries ...